512 related articles for article (PubMed ID: 33141814)
21. Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.
Calligari P; Bobone S; Ricci G; Bocedi A
Viruses; 2020 Apr; 12(4):. PubMed ID: 32295237
[TBL] [Abstract][Full Text] [Related]
22. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
Martinez MA
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
[TBL] [Abstract][Full Text] [Related]
23. Repurposing old drugs as antiviral agents for coronaviruses.
Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
[TBL] [Abstract][Full Text] [Related]
24. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Nov; 16(714):2190. PubMed ID: 33174705
[No Abstract] [Full Text] [Related]
25. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
26. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
27. [Not Available].
Meylan P
Rev Med Suisse; 2020 Nov; 16(714):2190-2191. PubMed ID: 33174706
[No Abstract] [Full Text] [Related]
28. [Characteristics of SARS-CoV-2 and potential pharmacological treatment].
Pawlik L; Śpiołek E; Fichna J; Tarasiuk A
Postepy Biochem; 2020 May; 66(2):83-90. PubMed ID: 32700510
[TBL] [Abstract][Full Text] [Related]
29. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
[TBL] [Abstract][Full Text] [Related]
30. Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
Clementi N; Ferrarese R; Criscuolo E; Diotti RA; Castelli M; Scagnolari C; Burioni R; Antonelli G; Clementi M; Mancini N
J Infect Dis; 2020 Aug; 222(5):722-725. PubMed ID: 32559285
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause.
Fernandez-Gutierrez B
Reumatol Clin (Engl Ed); 2020; 16(4):253-254. PubMed ID: 32345483
[No Abstract] [Full Text] [Related]
32. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Jans DA; Wagstaff KM
Cells; 2020 Sep; 9(9):. PubMed ID: 32942671
[TBL] [Abstract][Full Text] [Related]
33. Point mutation bias in SARS-CoV-2 variants results in increased ability to stimulate inflammatory responses.
Kosuge M; Furusawa-Nishii E; Ito K; Saito Y; Ogasawara K
Sci Rep; 2020 Oct; 10(1):17766. PubMed ID: 33082451
[TBL] [Abstract][Full Text] [Related]
34. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4
Wang M; Luo L; Bu H; Xia H
Int J Infect Dis; 2020 Jul; 96():148-150. PubMed ID: 32335339
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
36. The Virus that Changed Spain: Impact of COVID-19 on People with HIV.
Ballester-Arnal R; Gil-Llario MD
AIDS Behav; 2020 Aug; 24(8):2253-2257. PubMed ID: 32342259
[No Abstract] [Full Text] [Related]
37. Evelina Tacconelli-two viruses, two wars.
Kirby T
Lancet Infect Dis; 2020 Oct; 20(10):1132. PubMed ID: 32979331
[No Abstract] [Full Text] [Related]
38. Presence of SARS-CoV-2 RNA in isolation ward environment 28 days after exposure.
Zhou Y; Zeng Y; Chen C
Int J Infect Dis; 2020 Aug; 97():258-259. PubMed ID: 32534140
[TBL] [Abstract][Full Text] [Related]
39. Herpes zoster ophthalmicus in COVID-19 patients.
Nofal A; Fawzy MM; Sharaf El Deen SM; El-Hawary EE
Int J Dermatol; 2020 Dec; 59(12):1545-1546. PubMed ID: 33040343
[No Abstract] [Full Text] [Related]
40. Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic.
Abouleish M; El-Keblawy A; Mosa KA; Soliman SSM
Curr Top Med Chem; 2020; 20(22):1958-1961. PubMed ID: 33040729
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
